Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicia LeMoine

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Obstetrics and Gynecology|June 4, 2025
Expanded discussion of limitations for impact of glucagon-like peptide-1 receptor agonist use association with decreased risk of adverse obstetrical outcomesMarisa R Imbroane, Felicia LeMoine, Christopher T Nau
American Journal of Obstetrics and Gynecology|January 23, 2025
Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomesMarisa R Imbroane, Felicia LeMoine, Christopher T Nau
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 26, 2024
Autoimmune Condition Diagnosis Following Recurrent Pregnancy LossMarisa R Imbroane, Felicia LeMoine, Kelly S Gibson
Surgery|April 11, 2021
Surgical site infection risk in cesarean delivery patients with obesity after negative pressure wound therapy: A retrospective cohort studySarah Buzhardt, Andrew G Chapple, Felicia LeMoine, et al.
AJP Reports|December 9, 2020
Neonatal Survivability following Previable PPROM after Hospital Readmission for InterventionFelicia LeMoine, Robert C Moore, Andrew Chapple, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|July 27, 2025
Diagnosis and management of large placental chorioangiomasFelicia LeMoine, Neha Agarwal, Sarah Naranjo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Obstetrics and Gynecology|June 4, 2025
Expanded discussion of limitations for impact of glucagon-like peptide-1 receptor agonist use association with decreased risk of adverse obstetrical outcomesMarisa R Imbroane, Felicia LeMoine, Christopher T Nau
American Journal of Obstetrics and Gynecology|January 23, 2025
Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomesMarisa R Imbroane, Felicia LeMoine, Christopher T Nau
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 26, 2024
Autoimmune Condition Diagnosis Following Recurrent Pregnancy LossMarisa R Imbroane, Felicia LeMoine, Kelly S Gibson
Surgery|April 11, 2021
Surgical site infection risk in cesarean delivery patients with obesity after negative pressure wound therapy: A retrospective cohort studySarah Buzhardt, Andrew G Chapple, Felicia LeMoine, et al.
AJP Reports|December 9, 2020
Neonatal Survivability following Previable PPROM after Hospital Readmission for InterventionFelicia LeMoine, Robert C Moore, Andrew Chapple, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|July 27, 2025
Diagnosis and management of large placental chorioangiomasFelicia LeMoine, Neha Agarwal, Sarah Naranjo, et al.
Pageof 1